Maverick Capital’s Integra LifeSciences IART Stock Holding History

Maverick Capital’s Portfolio IART Stock Details IART Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$679K	Buy	+72,108	New	+$792K	0.01%	195
2024 Q2	–	Sell	-9,419	Closed	-$334K	–	369
2024 Q1	$334K	Buy	9,419 +767	+9%	+$30.7K	0.01%	321
2023 Q4	$377K	Buy	8,652 +1,184	+16%	+$46.6K	0.01%	243
2023 Q3	$285K	Sell	7,468 -2,627	-26%	-$111K	0.01%	232
2023 Q2	$415K	Sell	10,095 -61	-0.6%	-$2.94K	0.01%	276
2023 Q1	$583K	Buy	10,156 +4,029	+66%	+$227K	0.01%	219
2022 Q4	$344K	Buy	+6,127	New	+$312K	0.01%	245
2021 Q4	–	Sell	-7,007	Closed	-$480K	–	470
2021 Q3	$480K	Sell	7,007 -15,292	-69%	-$1.08M	﹤0.01%	443
2021 Q2	$1.52M	Buy	22,299 +12,447	+126%	+$880K	0.01%	197
2021 Q1	$681K	Sell	9,852 -3,254	-25%	-$220K	0.01%	346
2020 Q4	$851K	Sell	13,106 -7,786	-37%	-$419K	0.01%	257
2020 Q3	$987K	Buy	+20,892	New	+$994K	0.02%	294

Other funds holding IART

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

PCMI

Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Maverick Capital's IART Position: Q1 2026 in Review

Maverick Capital opened a new position in Integra LifeSciences (IART) in Q1 2026: 72,108 shares worth $679K. The stake represents 0.01% of the portfolio and ranks #195 among its holdings. This is a return to the name: Maverick Capital previously reported a position in IART as recently as Q1 2024.

Maverick Capital first reported a position in IART in Q3 2020 and has held it in 12 quarters since. The position peaked at $1.52M in Q2 2021. 201 funds tracked by Wall St. Rank hold IART as of Q1 2026.

Maverick Capital held 72,108 shares of Integra LifeSciences worth $679K as of Q1 2026.
Integra LifeSciences was a new Maverick Capital position in Q1 2026.
Integra LifeSciences made up 0.01% of Maverick Capital's portfolio in Q1 2026, its #195 holding.
Maverick Capital first reported a position in Integra LifeSciences in Q3 2020 and has held it in 12 quarters since.
Maverick Capital's Integra LifeSciences position peaked at $1.52M in Q2 2021.
201 funds tracked by Wall St. Rank held Integra LifeSciences as of Q1 2026.

Based on Maverick Capital's 13F filing for Q1 2026, filed 15 May 2026.